Mine Safety and Health Research Advisory Committee, 26548-26549 [2023-09068]
Download as PDF
<![CDATA[
26548
Federal Register / Vol. 88, No. 83 / Monday, May 1, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
register at https://www.cdc.gov/hicpac.
All registered participants will receive
instructions shortly before the meeting.
Please click first link for day one and
the second link for day two to join the
webinar:
https://cdc.zoomgov.com/j/
1616828862?pwd=N3hmSTEvQjQ3ZHF
ScVMyM1k2Mk8yUT09.
Meeting ID: 161 682 8862.
Passcode: 74249065.
https://cdc.zoomgov.com/j/
1614944394?pwd=
UWdBRDNNK2pDdS9
PMjlMZzYvRVFzZz09.
Meeting ID: 161 494 4394.
Passcode: 26658671.
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., HICPAC, National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention, l600
Clifton Road NE, Mailstop H16–3,
Atlanta, Georgia 30329. Telephone (404)
718–8039; Email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion, the Director,
NCEZID, the Director, CDC, and the
Secretary, Health and Human Services,
regarding (1) the practice of healthcare
infection prevention and control; (2)
strategies for surveillance, prevention,
and control of infections, antimicrobial
resistance, and related events in settings
where healthcare is provided; and (3)
periodic updating of CDC guidelines
and other policy statements regarding
prevention of healthcare-associated
infections and healthcare-related
conditions.
Matters To Be Considered: The agenda
will include updates on CDC’s activities
for prevention of healthcare-associated
infections. It will also include updates
from the following HICPAC workgroups:
the Isolation Precautions Guideline
workgroup, the Dental Unit Waterline
Guideline Workgroup, the Healthcare
Personnel Guideline Workgroup, the
Neonatal Intensive Care Unit Guideline
Workgroup, and the National Healthcare
Safety Network Workgroup. The agenda
also includes updates on CDC and
DHQP activities. Agenda items are
subject to change as priorities dictate.
Public Participation
Oral Public Comment: Time will be
available for public comment. Members
of the public who wish to provide
public comments should plan to attend
the public comment session at the start
time listed. Please note that the public
comment period may end before the
time indicated, following the last call
for comments.
VerDate Sep<11>2014
17:10 Apr 28, 2023
Jkt 259001
Written Public Comment: The public
is welcomed to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed above. The deadline for receipt of
written public comment is May 26,
2023. All requests must contain the
name, address, and organizational
affiliation of the speaker, as well as the
topic being addressed. Written
comments should not exceed one singlespaced typed page in length and
delivered in 3 minutes or less. Written
comments received in advance of the
meeting will be included in the official
record of the meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–09063 Filed 4–28–23; 8:45 am]
BILLING CODE 4163–19–P
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC); Notice of Charter
Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter renewal.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), announces the renewal
of the charter of the Advisory
Committee to the Director (ACD).
FOR FURTHER INFORMATION CONTACT:
Bridget Richards, MPH, Office of the
Chief of Staff, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop H21–10, Atlanta,
Georgia 30329–4027; Telephone: (404)
718–5028; Email: ACDirector@cdc.gov.
SUPPLEMENTARY INFORMATION: CDC is
providing notice under 5 U.S.C. 1001–
1014. This charter has been renewed for
SUMMARY:
Frm 00033
Fmt 4703
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–09071 Filed 4–28–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Mine Safety and Health Research
Advisory Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
Mine Safety and Health Research
Advisory Committee (MSHRAC). This is
a hybrid meeting, accessible both in
person and virtually. It is open to the
public and limited only by the space
available and the number of web
conference lines available. Time will be
available for public comment.
DATES: The meeting will be held on May
24, 2023, from 8:30 a.m. to 4:25 p.m.,
PDT.
ADDRESSES: Centers for Disease Control
and Prevention, National Institute for
Occupational Safety and Health,
Spokane Campus, 315 East Montgomery
Avenue, Spokane, Washington 99207–
2291. The conference room space
accommodates approximately 49
people.
Please note that the meeting location
is a federal facility, and in-person access
is limited to United States citizens
unless prior authorizations, taking up to
30 days, have been made.
If you wish to attend the meeting,
either in person or virtually, please
contact Ms. Berni Metzger by email at
Metzger@cdc.gov or by phone at (412)
386–4541 at least 5 business days in
advance of the meeting. If you are
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
a two-year period through April 15,
2025.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sfmt 4703
E:\FR\FM\01MYN1.SGM
01MYN1
Federal Register / Vol. 88, No. 83 / Monday, May 1, 2023 / Notices
attending virtually, she will provide you
with the Zoom web conference access
information (500 web conference lines
are available).
FOR FURTHER INFORMATION CONTACT:
George W. Luxbacher, PE, Ph.D.,
Designated Federal Officer, Mine Safety
and Health Research Advisory
Committee, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop V24–4,
Atlanta, Georgia 30329–4027.
Telephone: (404) 498–2808; Email:
GLuxbacher@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Mine Safety and Health
Research Advisory Committee
(MSHRAC) is charged with providing
advice to the Secretary, Department of
Health and Human Services; the
Director, Centers for Disease Control
and Prevention; and the Director,
National Institute for Occupational
Safety and Health (NIOSH), on priorities
in mine safety and health research,
including grants and contracts for such
research, 30 U.S.C. 812(b)(2), Section
102(b)(2).
Matters To Be Considered: The agenda
will include presentations of and
discussions on current NIOSH mining
safety and health research projects,
focusing on the Spokane Mining
Research Division. Agenda items are
subject to change as priorities dictate.
lotter on DSK11XQN23PROD with NOTICES1
Public Participation
Written Public Comment: The public
may submit written comments or
questions in advance of the meeting, to
the Designated Federal Officer (see FOR
FURTHER INFORMATION CONTACT above).
Written comments received in advance
of the meeting will be included in the
official record of the meeting, and
questions will be answered during the
oral comment period open to public
participation.
Oral Public Comment: The meeting
will include time for members of the
public to make an oral comment. The
public comment session will be held on
May 24, 2023, at 3:15 p.m., PDT, or at
the conclusion of the presentations and
discussion, and will conclude at 3:45
p.m., PDT, or following the final call for
public comment, whichever comes first.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
17:10 Apr 28, 2023
Jkt 259001
26549
Prevention and the Agency for Toxic
Substances and Disease Registry.
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–09068 Filed 4–28–23; 8:45 am]
[FR Doc. 2023–09064 Filed 4–28–23; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
[60Day–23–0106; Docket No. CDC–2023–
0029]
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
PAR 18–812, NIOSH Member Conflict
Review.
Date: June 8, 2023.
Time: 1 p.m.–3 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Michael Goldcamp, Ph.D., Scientific
Review Officer, Office of Extramural
Programs, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1095 Willowdale Road, Morgantown,
West Virginia 26506. Telephone: (304)
285–5951; Email: MGoldcamp@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Preventive
Health and Health Services Block Grant.
CDC will use the Block Grant
Information System to collect recipient
data, monitor awardees’ progress,
identify activities and personnel
supported with Block Grant funding,
conduct compliance reviews of Block
Grant recipients, and promote the use of
evidence-based guidelines and
interventions in accordance with
legislative mandates.
DATES: CDC must receive written
comments on or before June 30, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2023–
0029 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
SUMMARY:
E:\FR\FM\01MYN1.SGM
01MYN1
]]>Agencies
[Federal Register Volume 88, Number 83 (Monday, May 1, 2023)]
[Notices]
[Pages 26548-26549]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09068]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Mine Safety and Health Research Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the Mine Safety and Health Research Advisory Committee (MSHRAC).
This is a hybrid meeting, accessible both in person and virtually. It
is open to the public and limited only by the space available and the
number of web conference lines available. Time will be available for
public comment.
DATES: The meeting will be held on May 24, 2023, from 8:30 a.m. to 4:25
p.m., PDT.
ADDRESSES: Centers for Disease Control and Prevention, National
Institute for Occupational Safety and Health, Spokane Campus, 315 East
Montgomery Avenue, Spokane, Washington 99207-2291. The conference room
space accommodates approximately 49 people.
Please note that the meeting location is a federal facility, and
in-person access is limited to United States citizens unless prior
authorizations, taking up to 30 days, have been made.
If you wish to attend the meeting, either in person or virtually,
please contact Ms. Berni Metzger by email at [email protected] or by
phone at (412) 386-4541 at least 5 business days in advance of the
meeting. If you are
[[Page 26549]]
attending virtually, she will provide you with the Zoom web conference
access information (500 web conference lines are available).
FOR FURTHER INFORMATION CONTACT: George W. Luxbacher, PE, Ph.D.,
Designated Federal Officer, Mine Safety and Health Research Advisory
Committee, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention, 1600 Clifton Road NE,
Mailstop V24-4, Atlanta, Georgia 30329-4027. Telephone: (404) 498-2808;
Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Mine Safety and Health Research Advisory Committee
(MSHRAC) is charged with providing advice to the Secretary, Department
of Health and Human Services; the Director, Centers for Disease Control
and Prevention; and the Director, National Institute for Occupational
Safety and Health (NIOSH), on priorities in mine safety and health
research, including grants and contracts for such research, 30 U.S.C.
812(b)(2), Section 102(b)(2).
Matters To Be Considered: The agenda will include presentations of
and discussions on current NIOSH mining safety and health research
projects, focusing on the Spokane Mining Research Division. Agenda
items are subject to change as priorities dictate.
Public Participation
Written Public Comment: The public may submit written comments or
questions in advance of the meeting, to the Designated Federal Officer
(see FOR FURTHER INFORMATION CONTACT above). Written comments received
in advance of the meeting will be included in the official record of
the meeting, and questions will be answered during the oral comment
period open to public participation.
Oral Public Comment: The meeting will include time for members of
the public to make an oral comment. The public comment session will be
held on May 24, 2023, at 3:15 p.m., PDT, or at the conclusion of the
presentations and discussion, and will conclude at 3:45 p.m., PDT, or
following the final call for public comment, whichever comes first.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-09068 Filed 4-28-23; 8:45 am]
BILLING CODE 4163-18-P
